November 2022 – Further Group, a leading specialist in the design and development of niche health insurance products and services, has launched Precision CancerCare™, the market’s first-of-a-kind precision oncology solution for insurers and employers.
Precision CancerCare™ provides individuals diagnosed with cancer, the possibility to have a blood, or a tumour biopsy sample analysed by the most advanced laboratories, using molecular profiling tests such as Next Generation Sequencing, and have the results translated by an expert medical board, made up of the world’s leading geneticists and oncologists, into a personalised (targeted) treatment plan.
The service will deliver a detailed report from Further’s designated expert medical board with specific treatment recommendations compatible with the unique genetic profile of each individual. Further will then provide navigational support including, where indicated, the search for eligible clinical trials. Where the molecular profiling analysis detects a heredity mutation, direct family members will also be tested, and genetic counselling provided.
If purchased together with Further’s flagship Critical Advantage™ solution, the full cost of travel, accommodation and personalised cancer treatment in world-leading facilities is also covered, up to €2 million.
CEO of Further Group, Frank Ahedo, commented:
“With the addition of our new Precision CancerCare™ service, we continue to breakdown geographical and financial barriers to provide equitable access to the latest treatments and technologies for serious illnesses, such as cancer, as well as making sure that personal support is there every step of the way.
Understanding the genetic profile of a cancer helps get the right, individualised treatment improving the chances of a successful outcome.
Our turnkey solution, with service only or fully insured options, is available to employers and insurers directly from Further and through selected broker and distributor networks.”
For more information visit www.wegofurther.com/precisionmedicine/